Home > PS Ratio > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of SOTAC PHARMACEUTICALS is 1.41.

Share Price ₹115.0May 30,2024
Market Cap ₹127.7 Cr
Sales-TTM₹90.2 CrTTM-Consolidated Results
Price/Sales1.41xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of SOTAC PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SOTAC PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹127.7 Cr] as on May 30,2024

(/) Sales [ ₹90.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.41x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SOTAC PHARMACEUTICALS , the investors are currently willing to pay '1.41 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SOTAC PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of SOTAC PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of SOTAC PHARMACEUTICALS


PS Ratio Performance Analysis for SOTAC PHARMACEUTICALS

- SOTAC PHARMACEUTICALS 's latest p/e ratio is 1.41x.

- SOTAC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 0.00x.

- SOTAC PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, SOTAC PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 0x.

- SOTAC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does SOTAC PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SOTAC PHARMACEUTICALS 90.21.41127.7
SUN PHARMACEUTICAL INDUSTRIES LTD48,496.97.22350,195.0
CIPLA LTD25,774.14.59118,275.0
DR REDDYS LABORATORIES LTD28,011.13.5098,034.1
ZYDUS LIFESCIENCES LTD19,547.45.27102,998.0
DIVIS LABORATORIES LTD7,845.014.93117,130.0
MANKIND PHARMA LTD10,334.88.1283,883.0
TORRENT PHARMACEUTICALS LTD10,728.08.3989,994.3
LUPIN LTD20,010.83.5971,920.7
AUROBINDO PHARMA LTD29,001.92.4270,303.8
ABBOTT INDIA LTD5,848.99.4455,229.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SOTAC PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.41x
Max industry PS 14.93x
Median industry PS 5.27x
Average industry PS 6.26x



You may also like the below Video Courses